Therma Bright (TSE:THRM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Therma Bright Inc. has successfully partnered with Quantify Medical as a nationwide U.S. distributor for its Venowave VW5 device, which has seen initial success in sales and a Medicare/Medicaid reimbursement test. The company has also completed the first tranche of a non-brokered private placement, raising CAD $174,900 towards a projected CAD $6 million financing.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money